Targeting proteinase-activated receptors: therapeutic potential and challenges (original) (raw)

• Rieser, P. The insulin-like action of pepsin and pepsinogen. Acta Endocrinol. 54, 375–379 (1967).
  CAS Google Scholar
• Rieser, P. & Rieser, C. H. Anabolic responses of diaphragm muscle to insulin and to other pancreatic proteins. Proc. Soc. Exp. Biol. Med. 116, 669–671 (1964).
  CAS PubMed Google Scholar
• Burger, M. M. Proteolytic enzymes initiating cell division and escape from contact inhibition of growth. Nature 227, 170–171 (1970).
  CAS PubMed Google Scholar
• Sefton, B. M. & Rubin, H. Release from density dependent growth inhibition by proteolytic enzymes. Nature 227, 843–845 (1970).
  CAS PubMed Google Scholar
• Chen, L. B. & Buchanan, J. M. Mitogenic activity of blood components. I. Thrombin and prothrombin. Proc. Natl Acad. Sci. USA 72, 131–135 (1975).
  CAS PubMed PubMed Central Google Scholar
• Carney, D. H. & Cunningham, D. D. Transmembrane action of thrombin initiates chick cell division. J. Supramol. Struct. 9, 337–350 (1978).
  CAS PubMed Google Scholar
• Carney, D. H. & Cunningham, D. D. Initiation of chick cell division by trypsin action at the cell surface. Nature 268, 602–606 (1977).
  CAS PubMed Google Scholar
• Coughlin, S. R. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Thromb. Haemost. 3, 1800–1814 (2005).
  CAS PubMed Google Scholar
• Ramachandran, R. & Hollenberg, M. D. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br. J. Pharmacol. 153 (Suppl. 1), 263–282 (2008).
  Google Scholar
• Adams, M. N. et al. Structure, function and pathophysiology of protease activated receptors. Pharmacol. Ther. 130, 248–282 (2011).
  CAS PubMed Google Scholar
• Vu, T. K., Hung., D. T., Wheaton, V. I. & Coughlin, S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057–1068 (1991). This study described the cloning of the human thrombin receptor and identified the novel 'tethered ligand' mechanism of activation.
  CAS PubMed Google Scholar
• Rasmussen, U. B. et al. cDNA cloning and expression of a hamster α-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett. 288, 123–128 (1991). This was one of the first reports to describe the cloning and functional expression of the thrombin receptor in mammalian cells.
  CAS PubMed Google Scholar
• Nystedt, S., Emilsson, K., Wahlestedt, C. & Sundelin, J. Molecular cloning of a potential proteinase activated receptor. Proc. Natl Acad. Sci. USA 91, 9208–9212 (1994).
  CAS PubMed PubMed Central Google Scholar
• Nystedt, S., Emilsson, K., Larsson, A. K., Strombeck, B. & Sundelin, J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur. J. Biochem. 232, 84–89 (1995).
  CAS PubMed Google Scholar
• Ishihara, H. et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386, 502–506 (1997).
  CAS PubMed Google Scholar
• Kahn, M. L. et al. A dual thrombin receptor system for platelet activation. Nature 394, 690–694 (1998).
  CAS PubMed Google Scholar
• Xu, W. F. et al. Cloning and characterization of human protease-activated receptor 4. Proc. Natl Acad. Sci. USA 95, 6642–6646 (1998).
  CAS PubMed PubMed Central Google Scholar
• Nakanishi-Matsui, M. et al. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404, 609–613 (2000).
  CAS PubMed Google Scholar
• McLaughlin, J. N., Patterson, M. M. & Malik, A. B. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc. Natl Acad. Sci. USA 104, 5662–5667 (2007).
  CAS PubMed PubMed Central Google Scholar
• Scarborough, R. M. et al. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J. Biol. Chem. 267, 13146–13149 (1992).
  CAS PubMed Google Scholar
• Hollenberg, M. D., Saifeddine, M., Al-Ani, B. & Kawabata, A. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can. J. Physiol. Pharmacol. 75, 832–841 (1997).
  CAS PubMed Google Scholar
• McGuire, J. J., Dai, J., Andrade-Gordon, P., Triggle, C. R. & Hollenberg, M. D. Proteinase-activated receptor-2 (PAR2): vascular effects of a PAR2-derived activating peptide via a receptor different than PAR2. J. Pharmacol. Exp. Ther. 303, 985–992 (2002).
  CAS PubMed Google Scholar
• Liu, Q. et al. The distinct roles of two GPCRs, MrgprC11 and PAR2, in itch and hyperalgesia. Sci. Signal. 4, ra45 (2011).
  CAS PubMed PubMed Central Google Scholar
• Defea, K. β-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction. Br. J. Pharmacol. 153 (Suppl. 1), 298–309 (2008).
  Google Scholar
• Dulon, S. et al. Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases. Am. J. Respir. Cell. Mol. Biol. 28, 339–346 (2003).
  CAS PubMed Google Scholar
• Renesto, P. et al. Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor. Blood 89, 1944–1953 (1997).
  CAS PubMed Google Scholar
• Ramachandran, R. et al. Neutrophil elastase acts as a biased agonist for proteinase activated receptor-2 (PAR2). J. Biol. Chem. 286, 24638–24648 (2011). This was one of the first studies to identify an endogenous proteolytic mechanism that can stimulate biased signalling through PAR2.
  CAS PubMed PubMed Central Google Scholar
• Rajagopal, S., Rajagopal, K. & Lefkowitz, R. J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nature Rev. Drug Discov. 9, 373–386 (2011). This is an excellent overview of biased signalling involving GPCRs and β-arrestin.
  Google Scholar
• Kenakin, T. & Miller, L. J. Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol. Rev. 62, 265–304 (2010). This is a comprehensive overview of the concept of functional selectivity in GPCRs and its relevance to drug discovery.
  CAS PubMed PubMed Central Google Scholar
• Kenakin, T. Functional selectivity and biased receptor signaling. J. Pharmacol. Exp. Ther. 336, 296–302 (2011).
  CAS PubMed Google Scholar
• Shapiro, M. J., Trejo, J., Zeng, D. & Coughlin, S. R. Role of the thrombin receptor's cytoplasmic tail in intracellular trafficking. Distinct determinants for agonist-triggered versus tonic internalization and intracellular localization. J. Biol. Chem. 271, 32874–32880 (1996).
  CAS PubMed Google Scholar
• Shapiro, M. J. & Coughlin, S. R. Separate signals for agonist-independent and agonist-triggered trafficking of protease-activated receptor 1. J. Biol. Chem. 273, 29009–29014 (1998).
  CAS PubMed Google Scholar
• Ishii, K. et al. Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. J. Biol. Chem. 269, 1125–1130 (1994).
  CAS PubMed Google Scholar
• Tiruppathi, C. et al. G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells. Proc. Natl Acad. Sci. USA 97, 7440–7445 (2000).
  CAS PubMed PubMed Central Google Scholar
• Wolfe, B. L., Marchese, A. & Trejo, J. Ubiquitination differentially regulates clathrin-dependent internalization of protease-activated receptor-1. J. Cell Biol. 177, 905–916 (2007).
  CAS PubMed PubMed Central Google Scholar
• Paing, M. M., Johnston, C. A., Siderovski, D. P. & Trejo, J. Clathrin adaptor AP2 regulates thrombin receptor constitutive internalization and endothelial cell resensitization. Mol. Cell Biol. 26, 3231–3242 (2006).
  CAS PubMed PubMed Central Google Scholar
• Paing, M. M., Stutts, A. B., Kohout, T. A., Lefkowitz, R. J. & Trejo, J. β-arrestins regulate protease-activated receptor-1 desensitization but not internalization or down-regulation. J. Biol. Chem. 277, 1292–1300 (2002).
  CAS PubMed Google Scholar
• Chen, B. et al. Adaptor protein complex-2 (AP-2) and epsin-1 mediate protease-activated receptor-1 internalization via phosphorylation- and ubiquitination-dependent sorting signals. J. Biol. Chem. 286, 40760–40770 (2011).
  CAS PubMed PubMed Central Google Scholar
• Bohm, S. K. et al. Mechanisms of desensitization and resensitization of proteinase-activated receptor-2. J. Biol. Chem. 271, 22003–22016 (1996).
  CAS PubMed Google Scholar
• Seatter, M. J. et al. The role of the C-terminal tail in protease-activated receptor-2-mediated Ca2+ signalling, proline-rich tyrosine kinase-2 activation, and mitogen-activated protein kinase activity. Cell Signal. 16, 21–29 (2004).
  CAS PubMed Google Scholar
• Ricks, T. K. & Trejo, J. Phosphorylation of protease-activated receptor-2 differentially regulates desensitization and internalization. J. Biol. Chem. 284, 34444–34457 (2009).
  CAS PubMed PubMed Central Google Scholar
• Dery, O., Thoma, M. S., Wong, H., Grady, E. F. & Bunnett, N. W. Trafficking of proteinase-activated receptor-2 and β-arrestin-1 tagged with green fluorescent protein. β-arrestin-dependent endocytosis of a proteinase receptor. J. Biol. Chem. 274, 18524–18535 (1999).
  CAS PubMed Google Scholar
• Hasdemir, B., Murphy, J. E., Cottrell, G. S. & Bunnett, N. W. Endosomal deubiquitinating enzymes control ubiquitination and down-regulation of protease-activated receptor 2. J. Biol. Chem. 284, 28453–28466 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hasdemir, B., Bunnett, N. W. & Cottrell, G. S. Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) mediates post-endocytic trafficking of protease-activated receptor 2 and calcitonin receptor-like receptor. J. Biol. Chem. 282, 29646–29657 (2007).
  CAS PubMed Google Scholar
• Shapiro, M. J., Weiss, E. J., Faruqi, T. R. & Coughlin, S. R. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J. Biol. Chem. 275, 25216–25221 (2000).
  CAS PubMed Google Scholar
• Li, D., D'Angelo, L., Chavez, M. & Woulfe, D. S. Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets. J. Biol. Chem. 286, 3805–3814 (2011).
  CAS PubMed Google Scholar
• Jacobs, S. & Cuatrecasas, P. The mobile receptor hypothesis and “cooperativity” of hormone binding. Application to insulin. Biochim. Biophys. Acta 433, 482–495 (1976).
  CAS PubMed Google Scholar
• de Haen, C. The non-stoichiometric floating receptor model for hormone sensitive adenylyl cyclase. J. Theor. Biol. 58, 383–400 (1976).
  CAS PubMed Google Scholar
• Urban, J. D. et al. Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp. Ther. 320, 1–13 (2007).
  CAS PubMed Google Scholar
• McLaughlin, J. N. et al. Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. J. Biol. Chem. 280, 25048–25059 (2005). This was one of the first studies to demonstrate clearly that different agonists could elicit distinct functional responses when acting at PAR1.
  CAS PubMed Google Scholar
• Russo, A., Soh, U. J., Paing, M. M., Arora, P. & Trejo, J. Caveolae are required for protease-selective signaling by protease-activated receptor-1. Proc. Natl Acad. Sci. USA 106, 6393–6397 (2009).
  CAS PubMed PubMed Central Google Scholar
• Awasthi, V., Mandal, S. K., Papanna, V., Rao, L. V. & Pendurthi, U. R. Modulation of tissue factor–factor VIIa signaling by lipid rafts and caveolae. Arterioscler. Thromb. Vasc. Biol. 27, 1447–1455 (2007).
  CAS PubMed PubMed Central Google Scholar
• Hamilton, J. R., Nguyen, P. B. & Cocks, T. M. Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries. Circ. Res. 82, 1306–1311 (1998).
  CAS PubMed Google Scholar
• Roy, S. S., Saifeddine, M., Loutzenhiser, R., Triggle, C. R. & Hollenberg, M. D. Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity. Br. J. Pharmacol. 123, 1434–1440 (1998).
  CAS PubMed PubMed Central Google Scholar
• Ballerio, R. et al. Distinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits. J. Thromb. Haemost. 5, 174–180 (2007).
  CAS PubMed Google Scholar
• Hamilton, J. R., Frauman, A. G. & Cocks, T. M. Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ. Res. 89, 92–98 (2001).
  CAS PubMed Google Scholar
• Moffatt, J. D. & Cocks, T. M. Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries. Br. J. Pharmacol. 125, 591–594 (1998).
  CAS PubMed PubMed Central Google Scholar
• Laniyonu, A. A. & Hollenberg, M. D. Vascular actions of thrombin receptor-derived polypeptides: structure–activity profiles for contractile and relaxant effects in rat aorta. Br. J. Pharmacol. 114, 1680–1686 (1995).
  CAS PubMed PubMed Central Google Scholar
• Kagota, S., Chia, E. & McGuire, J. J. Preserved arterial vasodilation via endothelial protease-activated receptor-2 in obese type 2 diabetic mice. Br. J. Pharmacol. 164, 358–371 (2011).
  CAS PubMed PubMed Central Google Scholar
• McGuire, J. J., Van Vliet, B. N. & Halfyard, S. J. Blood pressures, heart rate and locomotor activity during salt loading and angiotensin II infusion in protease-activated receptor 2 (PAR2) knockout mice. BMC Physiol. 8, 20 (2008).
  PubMed PubMed Central Google Scholar
• Hirano, K. & Hirano, M. Current perspective on the role of the thrombin receptor in cerebral vasospasm after subarachnoid hemorrhage. J. Pharmacol. Sci. 114, 127–133 (2010).
  CAS PubMed Google Scholar
• Hollenberg, M. D. Novel insights into the delayed vasospasm following subarachnoid haemorrhage: importance of proteinase signalling. Br. J. Pharmacol. 30 Jun 2011 (doi:10.1111/j.1476-5381.2011.01564.x).
  Google Scholar
• Kameda, K. et al. Combined argatroban and anti-oxidative agents prevents increased vascular contractility to thrombin and other ligands after subarachnoid hemorrhage. Br. J. Pharmacol. 13 May 2011 (doi:10.1111/j.1476-5381.2011.01485.x).
  Google Scholar
• Hung., D. T., Vu, T. K., Wheaton, V. I., Ishii, K. & Coughlin, S. R. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J. Clin. Invest. 89, 1350–1353 (1992).
  CAS PubMed PubMed Central Google Scholar
• Cook, J. J. et al. An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey. Circulation 91, 2961–2971 (1995).
  CAS PubMed Google Scholar
• Kahn, M. L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H. & Coughlin, S. R. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest. 103, 879–887 (1999).
  CAS PubMed PubMed Central Google Scholar
• Leger, A. J. et al. Blocking the protease-activated receptor 1–4 heterodimer in platelet-mediated thrombosis. Circulation 113, 1244–1254 (2006).
  CAS PubMed Google Scholar
• Covic, L., Gresser, A. L. & Kuliopulos, A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 39, 5458–5467 (2000).
  CAS PubMed Google Scholar
• Sevigny, L. M. et al. Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia. Arterioscler. Thromb. Vasc. Biol. 31, e100–e106 (2011).
  CAS PubMed PubMed Central Google Scholar
• Sambrano, G. R. et al. Cathepsin G activates protease-activated receptor-4 in human platelets. J. Biol. Chem. 275, 6819–6823 (2000).
  CAS PubMed Google Scholar
• Oikonomopoulou, K. et al. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs). Biol. Chem. 387, 817–824 (2006).
  CAS PubMed Google Scholar
• Santulli, R. J. et al. Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. Proc. Natl Acad. Sci. USA 92, 9151–9155 (1995).
  CAS PubMed PubMed Central Google Scholar
• Oikonomopoulou, K. et al. Proteinase-activated receptors, targets for kallikrein signaling. J. Biol. Chem. 281, 32095–32112 (2006).
  CAS PubMed Google Scholar
• Cornelissen, I. et al. Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis. Proc. Natl Acad. Sci. USA 107, 18605–18610 (2011).
  Google Scholar
• Vergnolle, N., Hollenberg, M. D., Sharkey, K. A. & Wallace, J. L. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br. J. Pharmacol. 127, 1083–1090 (1999). This study first established a role for PAR2 in regulating peripheral inflammation.
  CAS PubMed PubMed Central Google Scholar
• Vergnolle, N., Hollenberg, M. D. & Wallace, J. L. Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR1). Br. J. Pharmacol. 126, 1262–1268 (1999). This study first established a role for PAR1 in regulating peripheral inflammation.
  CAS PubMed PubMed Central Google Scholar
• Asfaha, S., Brussee, V., Chapman, K., Zochodne, D. W. & Vergnolle, N. Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br. J. Pharmacol. 135, 1101–1106 (2002).
  CAS PubMed PubMed Central Google Scholar
• Asfaha, S. et al. Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation. Br. J. Pharmacol. 150, 176–185 (2007).
  CAS PubMed Google Scholar
• Steinhoff, M. et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nature Med. 6, 151–158 (2000). This study first identified a role for neuronal PAR2 in regulating inflammatory responses.
  CAS PubMed Google Scholar
• Vergnolle, N. et al. Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nature Med. 7, 821–826 (2001).
  CAS PubMed Google Scholar
• Russell, F. A. & McDougall, J. J. Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation. Inflamm. Res. 58, 119–126 (2009).
  CAS PubMed Google Scholar
• Ferrell, W. R. et al. Essential role for proteinase-activated receptor-2 in arthritis. J. Clin. Invest. 111, 35–41 (2003). This study established PAR2 as a potential therapeutic target for joint inflammation.
  CAS PubMed PubMed Central Google Scholar
• Kelso, E. B. et al. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. J. Pharmacol. Exp. Ther. 316, 1017–1024 (2006). This study illustrated multiple strategies for targeting PAR2 to block the receptor-mediated inflammatory responses.
  CAS PubMed Google Scholar
• Howell, D. C. et al. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am. J. Pathol. 166, 1353–1365 (2005).
  CAS PubMed PubMed Central Google Scholar
• Scotton, C. J. et al. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J. Clin. Invest. 119, 2550–2563 (2009).
  CAS PubMed PubMed Central Google Scholar
• Chambers, R. C., Leoni, P., Blanc-Brude, O. P., Wembridge, D. E. & Laurent, G. J. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J. Biol. Chem. 275, 35584–35591 (2000).
  CAS PubMed Google Scholar
• Chambers, R. C. et al. Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1. Biochem. J. 333 (Pt 1), 121–127 (1998).
  CAS PubMed PubMed Central Google Scholar
• Bogatkevich, G. S., Tourkina, E., Silver, R. M. & Ludwicka-Bradley, A. Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J. Biol. Chem. 276, 45184–45192 (2001).
  CAS PubMed Google Scholar
• Riewald, M., Petrovan, R. J., Donner, A., Mueller, B. M. & Ruf, W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296, 1880–1882 (2002). This was the first study to demonstrate that biased PAR1 signalling by APC is distinct from thrombin-stimulated signalling, implying a role for APC–PAR1 signalling in sepsis.
  CAS PubMed Google Scholar
• Riewald, M. & Ruf, W. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling. J. Biol. Chem. 280, 19808–19814 (2005).
  CAS PubMed Google Scholar
• Yasui, H. et al. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am. J. Respir. Crit. Care Med. 163, 1660–1668 (2001).
  CAS PubMed Google Scholar
• Deng, X., Mercer, P. F., Scotton, C. J., Gilchrist, A. & Chambers, R. C. Thrombin induces fibroblast CCL2/JE production and release via coupling of PAR1 to Gαq and cooperation between ERK1/2 and Rho kinase signaling pathways. Mol. Biol. Cell 19, 2520–2533 (2008).
  CAS PubMed PubMed Central Google Scholar
• Ando, S. et al. Proteinase-activated receptor 4 stimulation-induced epithelial-mesenchymal transition in alveolar epithelial cells. Respir. Res. 8, 31 (2007).
  PubMed PubMed Central Google Scholar
• Ramachandran, R. et al. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L788–L798 (2007).
  CAS PubMed Google Scholar
• Ramachandran, R., Morice, A. H. & Compton, S. J. Proteinase-activated receptor 2 agonists upregulate granulocyte colony-stimulating factor, IL-8, and VCAM-1 expression in human bronchial fibroblasts. Am. J. Respir. Cell. Mol. Biol. 35, 133–141 (2006).
  CAS PubMed Google Scholar
• Akers, I. A. et al. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L193–L201 (2000).
  CAS PubMed Google Scholar
• Schmidlin, F. et al. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J. Immunol. 169, 5315–5321 (2002).
  PubMed Google Scholar
• Ebeling, C. et al. Proteinase-activated receptor 2 activation in the airways enhances antigen-mediated airway inflammation and airway hyperresponsiveness through different pathways. J. Allergy Clin. Immunol. 115, 623–630 (2005).
  CAS PubMed Google Scholar
• Ebeling, C., Lam, T., Gordon, J. R., Hollenberg, M. D. & Vliagoftis, H. Proteinase-activated receptor-2 promotes allergic sensitization to an inhaled antigen through a TNF-mediated pathway. J. Immunol. 179, 2910–2917 (2007).
  CAS PubMed Google Scholar
• Arizmendi, N. G. et al. Mucosal allergic sensitization to cockroach allergens is dependent on proteinase activity and proteinase-activated receptor-2 activation. J. Immunol. 186, 3164–3172 (2011).
  CAS PubMed Google Scholar
• Adam, E. et al. The house dust mite allergen Der p 1, unlike Der p 3, stimulates the expression of interleukin-8 in human airway epithelial cells via a proteinase-activated receptor-2-independent mechanism. J. Biol. Chem. 281, 6910–6923 (2006).
  CAS PubMed Google Scholar
• Asokananthan, N. et al. Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J. Immunol. 168, 3577–3585 (2002).
  CAS PubMed Google Scholar
• Asokananthan, N. et al. House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J. Immunol. 169, 4572–4578 (2002).
  CAS PubMed Google Scholar
• Page, K., Ledford, J. R., Zhou, P., Dienger, K. & Wills-Karp, M. Mucosal sensitization to German cockroach involves protease-activated receptor-2. Respir. Res. 11, 62 (2010).
  PubMed PubMed Central Google Scholar
• Cocks, T. M. et al. A protective role for protease-activated receptors in the airways. Nature 398, 156–160 (1999). This study demonstrated that epithelial PAR2 activation can stimulate the release of tracheal relaxing prostaglandins, suggesting a protective role for PAR2 in airway inflammatory diseases.
  CAS PubMed Google Scholar
• Moffatt, J. D., Jeffrey, K. L. & Cocks, T. M. Protease-activated receptor-2 activating peptide SLIGRL inhibits bacterial lipopolysaccharide-induced recruitment of polymorphonuclear leukocytes into the airways of mice. Am. J. Respir. Cell. Mol. Biol. 26, 680–684 (2002).
  CAS PubMed Google Scholar
• Vergnolle, N. Clinical relevance of proteinase activated receptors (PARs) in the gut. Gut 54, 867–874 (2005).
  CAS PubMed PubMed Central Google Scholar
• Mule, F., Pizzuti, R., Capparelli, A. & Vergnolle, N. Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon. Gut 53, 229–234 (2004).
  CAS PubMed PubMed Central Google Scholar
• Hollenberg, M. D., Saifeddine, M., Al-Ani, B. & Gui, Y. Proteinase-activated receptor 4 (PAR4): action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2. Can. J. Physiol. Pharmacol. 77, 458–464 (1999).
  CAS PubMed Google Scholar
• Buresi, M. C., Buret, A. G., Hollenberg, M. D. & MacNaughton, W. K. Activation of proteinase-activated receptor 1 stimulates epithelial chloride secretion through a unique MAP kinase- and cyclo-oxygenase-dependent pathway. FASEB J. 16, 1515–1525 (2002).
  CAS PubMed Google Scholar
• Buresi, M. C. et al. Activation of proteinase-activated receptor-1 inhibits neurally evoked chloride secretion in the mouse colon in vitro. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G337–G345 (2005).
  CAS PubMed Google Scholar
• Kong, W. et al. Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc. Natl Acad. Sci. USA 94, 8884–8889 (1997).
  CAS PubMed PubMed Central Google Scholar
• van der Merwe, J. Q., Hollenberg, M. D. & MacNaughton, W. K. EGF receptor transactivation and MAP kinase mediate proteinase-activated receptor-2-induced chloride secretion in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G441–G451 (2008).
  CAS PubMed Google Scholar
• Lau, C., Lytle, C., Straus, D. S. & DeFea, K. A. Apical and basolateral pools of proteinase-activated receptor-2 direct distinct signaling events in the intestinal epithelium. Am. J. Physiol. Cell Physiol. 300, C113–C123 (2011).
  CAS PubMed Google Scholar
• Chin, A. C. et al. Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability. Proc. Natl Acad. Sci. USA 100, 11104–11109 (2003).
  CAS PubMed PubMed Central Google Scholar
• Mule, F., Baffi, M. C. & Cerra, M. C. Dual effect mediated by protease-activated receptors on the mechanical activity of rat colon. Br. J. Pharmacol. 136, 367–374 (2002).
  CAS PubMed PubMed Central Google Scholar
• Saifeddine, M., Al-Ani, B., Sandhu, S., Wijesuriya, S. J. & Hollenberg, M. D. Contractile actions of proteinase-activated receptor-derived polypeptides in guinea-pig gastric and lung parenchymal strips: evidence for distinct receptor systems. Br. J. Pharmacol. 132, 556–566 (2001).
  CAS PubMed PubMed Central Google Scholar
• Mule, F., Baffi, M. C., Capparelli, A. & Pizzuti, R. Involvement of nitric oxide and tachykinins in the effects induced by protease-activated receptors in rat colon longitudinal muscle. Br. J. Pharmacol. 139, 598–604 (2003).
  CAS PubMed PubMed Central Google Scholar
• Zhao, A. & Shea-Donohue, T. PAR-2 agonists induce contraction of murine small intestine through neurokinin receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G696–G703 (2003).
  CAS PubMed Google Scholar
• Kawabata, A. et al. In vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouse. Br. J. Pharmacol. 133, 1213–1218 (2001).
  CAS PubMed PubMed Central Google Scholar
• Cenac, N. et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am. J. Pathol. 161, 1903–1915 (2002).
  CAS PubMed PubMed Central Google Scholar
• Hyun, E., Andrade-Gordon, P., Steinhoff, M. & Vergnolle, N. Protease-activated receptor-2 activation: a major actor in intestinal inflammation. Gut 57, 1222–1229 (2008).
  CAS PubMed Google Scholar
• Hyun, E., Andrade-Gordon, P., Steinhoff, M., Beck, P. L. & Vergnolle, N. Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitis. Inflamm. Res. 59, 699–709 (2010).
  CAS PubMed PubMed Central Google Scholar
• Hansen, K. K. et al. A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. Proc. Natl Acad. Sci. USA 102, 8363–8368 (2005).
  CAS PubMed PubMed Central Google Scholar
• Cottrell, G. S. et al. Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis. Gastroenterology 132, 2422–2437 (2007).
  CAS PubMed Google Scholar
• Cenac, N. et al. Role for protease activity in visceral pain in irritable bowel syndrome. J. Clin. Invest. 117, 636–647 (2007).
  CAS PubMed PubMed Central Google Scholar
• Gecse, K. et al. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 57, 591–599 (2008).
  CAS PubMed Google Scholar
• Cenac, N. et al. Proteinase-activated receptor-1 is an anti-inflammatory signal for colitis mediated by a type 2 immune response. Inflamm. Bowel Dis. 11, 792–798 (2005).
  PubMed Google Scholar
• Wee, J. L. et al. Protease-activated receptor-1 down-regulates the murine inflammatory and humoral response to Helicobacter pylori. Gastroenterology 138, 573–582 (2009).
  PubMed Google Scholar
• Fiorucci, S. et al. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc. Natl Acad. Sci. USA 98, 13936–13941 (2001).
  CAS PubMed PubMed Central Google Scholar
• Cattaruzza, F. et al. Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents. Am. J. Pathol. 169, 177–188 (2006).
  CAS PubMed PubMed Central Google Scholar
• Striggow, F. et al. Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur. J. Neurosci. 14, 595–608 (2001).
  CAS PubMed Google Scholar
• Henrich-Noack, P., Riek-Burchardt, M., Baldauf, K., Reiser, G. & Reymann, K. G. Focal ischemia induces expression of protease-activated receptor1 (PAR1) and PAR3 on microglia and enhances PAR4 labeling in the penumbra. Brain Res. 1070, 232–241 (2006).
  CAS PubMed Google Scholar
• Suo, Z., Wu, M., Citron, B. A., Gao, C. & Festoff, B. W. Persistent protease-activated receptor 4 signaling mediates thrombin-induced microglial activation. J. Biol. Chem. 278, 31177–31183 (2003).
  CAS PubMed Google Scholar
• Wang, H., Ubl, J. J. & Reiser, G. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 37, 53–63 (2002).
  CAS PubMed Google Scholar
• Scarisbrick, I. A., Isackson, P. J., Ciric, B., Windebank, A. J. & Rodriguez, M. MSP, a trypsin-like serine protease, is abundantly expressed in the human nervous system. J. Comp. Neurol. 431, 347–361 (2001).
  CAS PubMed Google Scholar
• Bernett, M. J. et al. Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 277, 24562–24570 (2002).
  CAS PubMed Google Scholar
• Sokolova, E. & Reiser, G. Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases. Thromb. Haemost. 100, 576–581 (2008).
  CAS PubMed Google Scholar
• Yoshida, S. & Shiosaka, S. Plasticity-related serine proteases in the brain. Int. J. Mol. Med. 3, 405–409 (1999).
  CAS PubMed Google Scholar
• Turgeon, V. L. & Houenou, L. J. The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system. Brain Res. Brain Res. Rev. 25, 85–95 (1997).
  CAS PubMed Google Scholar
• Noorbakhsh, F., Vergnolle, N., Hollenberg, M. D. & Power, C. Proteinase-activated receptors in the nervous system. Nature Rev. Neurosci. 4, 981–990 (2003).
  CAS Google Scholar
• Luo, W., Wang, Y. & Reiser, G. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Brain Res. Rev. 56, 331–345 (2007).
  CAS PubMed Google Scholar
• Vaughan, P. J., Pike, C. J., Cotman, C. W. & Cunningham, D. D. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 15, 5389–5401 (1995).
  CAS PubMed PubMed Central Google Scholar
• Donovan, F. M., Pike, C. J., Cotman, C. W. & Cunningham, D. D. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J. Neurosci. 17, 5316–5326 (1997).
  CAS PubMed PubMed Central Google Scholar
• Acharjee, S. et al. Proteinase-activated receptor-1 mediates dorsal root ganglion neuronal degeneration in HIV/AIDS. Brain 134, 3209–3221 (2011).
  PubMed PubMed Central Google Scholar
• Gan, J., Greenwood, S. M., Cobb, S. R. & Bushell, T. J. Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase-activated receptor-2. Br. J. Pharmacol. 163, 984–994 (2011).
  CAS PubMed PubMed Central Google Scholar
• Lohman, R. J., O'Brien, T. J. & Cocks, T. M. Protease-activated receptor-2 regulates trypsin expression in the brain and protects against seizures and epileptogenesis. Neurobiol. Dis. 30, 84–93 (2008).
  CAS PubMed Google Scholar
• Lohman, R. J., Jones, N. C., O'Brien, T. J. & Cocks, T. M. A regulatory role for protease-activated receptor-2 in motivational learning in rats. Neurobiol. Learn. Mem. 92, 301–309 (2009).
  CAS PubMed Google Scholar
• Junge, C. E. et al. The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc. Natl Acad. Sci. USA 100, 13019–13024 (2003).
  CAS PubMed PubMed Central Google Scholar
• Hamill, C. E., Mannaioni, G., Lyuboslavsky, P., Sastre, A. A. & Traynelis, S. F. Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function. Exp. Neurol. 217, 136–146 (2009).
  CAS PubMed PubMed Central Google Scholar
• Xue, M., Hollenberg, M. D., Demchuk, A. & Yong, V. W. Relative importance of proteinase-activated receptor-1 versus matrix metalloproteinases in intracerebral hemorrhage-mediated neurotoxicity in mice. Stroke 40, 2199–2204 (2009).
  CAS PubMed Google Scholar
• Boven, L. A. et al. Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis. J. Immunol. 170, 2638–2646 (2003). This was one of the first studies to show that PAR1 can be involved in CNS neurotoxicity.
  CAS PubMed Google Scholar
• Hamill, C. E. et al. Exacerbation of dopaminergic terminal damage in a mouse model of Parkinson's disease by the G-protein-coupled receptor protease-activated receptor 1. Mol. Pharmacol. 72, 653–664 (2007).
  CAS PubMed Google Scholar
• Lee, E. J. et al. α-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1. J. Immunol. 185, 615–623 (2010).
  CAS PubMed Google Scholar
• Nicole, O. et al. Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. J. Neurosci. 25, 4319–4329 (2005).
  CAS PubMed PubMed Central Google Scholar
• Wang, Y., Luo, W., Stricker, R. & Reiser, G. Protease-activated receptor-1 protects rat astrocytes from apoptotic cell death via JNK-mediated release of the chemokine GRO/CINC-1. J. Neurochem. 98, 1046–1060 (2006).
  CAS PubMed Google Scholar
• Thiyagarajan, M., Fernandez, J. A., Lane, S. M., Griffin, J. H. & Zlokovic, B. V. Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1. J. Neurosci. 28, 12788–12797 (2008).
  CAS PubMed PubMed Central Google Scholar
• Noorbakhsh, F. et al. Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. J. Immunol. 174, 7320–7329 (2005).
  CAS PubMed Google Scholar
• Noorbakhsh, F. et al. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 203, 425–435 (2006).
  PubMed PubMed Central Google Scholar
• Afkhami-Goli, A. et al. Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease. J. Immunol. 179, 5493–5503 (2007).
  CAS PubMed Google Scholar
• Jin, G. et al. Deficiency of PAR-2 gene increases acute focal ischemic brain injury. J. Cereb. Blood Flow Metab. 25, 302–313 (2005).
  CAS PubMed Google Scholar
• Mao, Y., Zhang, M., Tuma, R. F. & Kunapuli, S. P. Deficiency of PAR4 attenuates cerebral ischemia/reperfusion injury in mice. J. Cereb. Blood Flow Metab. 30, 1044–1052 (2010).
  CAS PubMed PubMed Central Google Scholar
• Guo, H. et al. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron 41, 563–572 (2004).
  CAS PubMed Google Scholar
• Even-Ram, S. C. et al. Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the αvβ5 integrin. J. Biol. Chem. 276, 10952–10962 (2001).
  CAS PubMed Google Scholar
• Even-Ram, S. et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nature Med. 4, 909–914 (1998).
  CAS PubMed Google Scholar
• Bar-Shavit, R. et al. PAR1 plays a role in epithelial malignancies: transcriptional regulation and novel signaling pathway. IUBMB Life 63, 397–402 (2011).
  CAS PubMed Google Scholar
• Nyberg, P., Ylipalosaari, M., Sorsa, T. & Salo, T. Trypsins and their role in carcinoma growth. Exp. Cell Res. 312, 1219–1228 (2006).
  CAS PubMed Google Scholar
• Soreide, K., Janssen, E. A., Korner, H. & Baak, J. P. Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis. J. Pathol. 209, 147–156 (2006).
  CAS PubMed Google Scholar
• Zwicker, J. I., Furie, B. C. & Furie, B. Cancer-associated thrombosis. Crit. Rev. Oncol. Hematol. 62, 126–136 (2007).
  PubMed Google Scholar
• Rickles, F. R. Mechanisms of cancer-induced thrombosis in cancer. Pathophysiol. Haemost. Thromb. 35, 103–110 (2006).
  PubMed Google Scholar
• Trivedi, V. et al. Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell 137, 332–343 (2009). This study showed that enzymes other than serine proteinases can activate PAR1 signalling by unmasking a non-canonical tethered ligand.
  CAS PubMed PubMed Central Google Scholar
• Boire, A. et al. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120, 303–313 (2005).
  CAS PubMed Google Scholar
• Salah, Z. et al. Identification of a novel functional androgen response element within hPar1 promoter: implications to prostate cancer progression. FASEB J. 19, 62–72 (2005).
  CAS PubMed Google Scholar
• Ramsay, A. J. et al. Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression. J. Biol. Chem. 283, 12293–12304 (2008).
  CAS PubMed Google Scholar
• Gratio, V. et al. Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells. Am. J. Pathol. 179, 2625–2636 (2011).
  CAS PubMed PubMed Central Google Scholar
• Gratio, V. et al. Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells. Am. J. Pathol. 176, 1452–1461 (2010).
  CAS PubMed PubMed Central Google Scholar
• Krenzer, S. et al. Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment. J. Invest. Dermatol. 131, 2281–2288 (2011).
  CAS PubMed PubMed Central Google Scholar
• Wang, J., Boerma, M., Kulkarni, A., Hollenberg, M. D. & Hauer-Jensen, M. Activation of protease activated receptor 2 by exogenous agonist exacerbates early radiation injury in rat intestine. Int. J. Radiat. Oncol. Biol. Phys. 77, 1206–1212 (2010).
  CAS PubMed PubMed Central Google Scholar
• Vergnolle, N. Protease-activated receptors as drug targets in inflammation and pain. Pharmacol. Ther. 123, 292–309 (2009).
  CAS PubMed Google Scholar
• Sevigny, L. M. et al. Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins. Proc. Natl Acad. Sci. USA 108, 8491–8496 (2011). This was one of the first studies to provide proof of concept that PAR2 pepducin antagonists are able to inhibit inflammatory responses in vivo.
  CAS PubMed PubMed Central Google Scholar
• Dowal, L. et al. Identification of an antithrombotic allosteric modulator that acts through helix 8 of PAR1. Proc. Natl Acad. Sci. USA 108, 2951–2956 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ruda, E. M., Scrutton, M. C., Manley, P. W. & Tuffin, D. P. Thrombin receptor antagonists: structure-activity relationships for the platelet thrombin receptor and effects on prostacyclin synthesis by human umbilical vein endothelial cells. Biochem. Pharmacol. 39, 373–381 (1990).
  CAS PubMed Google Scholar
• Ruda, E. M., Petty, A., Scrutton, M. C., Tuffin, D. P. & Manley, P. W. Identification of small peptide analogues having agonist and antagonist activity at the platelet thrombin receptor. Biochem. Pharmacol. 37, 2417–2426 (1988).
  CAS PubMed Google Scholar
• Andrade-Gordon, P. et al. Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor. Proc. Natl Acad. Sci. USA 96, 12257–12262 (1999). This study reported the first successful synthesis and use of a PAR1-targeted peptidomimetic antagonist.
  CAS PubMed PubMed Central Google Scholar
• Maryanoff, B. E., Zhang, H. C., Andrade-Gordon, P. & Derian, C. K. Discovery of potent peptide-mimetic antagonists for the human thrombin receptor, protease-activated receptor-1 (PAR-1). Curr. Med. Chem. Cardiovasc. Hematol. Agents 1, 13–36 (2003).
  CAS PubMed Google Scholar
• Andrade-Gordon, P. et al. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats. J. Pharmacol. Exp. Ther. 298, 34–42 (2001).
  CAS PubMed Google Scholar
• Derian, C. K. et al. Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates. J. Pharmacol. Exp. Ther. 304, 855–861 (2003).
  CAS PubMed Google Scholar
• Chackalamannil, S. et al. Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents. J. Med. Chem. 48, 5884–5887 (2005).
  CAS PubMed Google Scholar
• Chackalamannil, S. et al. Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity. J. Med. Chem. 51, 3061–3064 (2008).
  CAS PubMed Google Scholar
• Becker, R. C. et al. Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled Phase II study. Lancet 373, 919–928 (2009).
  CAS PubMed Google Scholar
• TRA*CER, Executive and Steering Committees. The thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA*CER) trial: study design and rationale. Am. Heart J. 158, 327–334 (2009).
• Morrow, D. A. et al. Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the thrombin-receptor antagonist in secondary prevention of atherothrombotic ischemic events (TRA 2 ˚P)-TIMI 50 trial. Am. Heart J. 158, 335–341 (2009).
  CAS PubMed Google Scholar
• Tricoci, P. et al. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. 13 Nov 2011 (doi:10.1056/NEJMoa1109719).
  CAS Google Scholar
• Feistritzer, C. & Riewald, M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105, 3178–3184 (2005).
  CAS PubMed Google Scholar
• Schuepbach, R. A., Feistritzer, C., Fernandez, J. A., Griffin, J. H. & Riewald, M. Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1. Thromb. Haemost. 101, 724–733 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kaneider, N. C. et al. 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nature Immunol. 8, 1303–1312 (2007).
  CAS Google Scholar
• Serebruany, V. L., Kogushi, M., Dastros-Pitei, D., Flather, M. & Bhatt, D. L. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease. Thromb. Haemost. 102, 111–119 (2009).
  CAS PubMed Google Scholar
• O'Donoghue, M. L. et al. Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of thrombin–acute coronary syndromes trial. Circulation 123, 1843–1853 (2011).
  CAS PubMed Google Scholar
• Wiviott, S. D. et al. Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of thrombin–coronary artery disease trial. Circulation 123, 1854–1863 (2011).
  CAS PubMed Google Scholar
• Goto, S., Ogawa, H., Takeuchi, M., Flather, M. D. & Bhatt, D. L. Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease. Eur. Heart J. 31, 2601–2613 (2010).
  CAS PubMed PubMed Central Google Scholar
• Chieng-Yane, P. et al. Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells. J. Pharmacol. Exp. Ther. 336, 643–651 (2011).
  CAS PubMed Google Scholar
• Perez, M. et al. Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo. J. Med. Chem. 52, 5826–5836 (2009).
  CAS PubMed Google Scholar
• Planty, B. et al. Exploration of a new series of PAR1 antagonists. Bioorg. Med. Chem. Lett. 20, 1735–1739 (2010).
  CAS PubMed Google Scholar
• Al-Ani, B., Saifeddine, M., Wijesuriya, S. J. & Hollenberg, M. D. Modified proteinase-activated receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin. J. Pharmacol. Exp. Ther. 300, 702–708 (2002).
  CAS PubMed Google Scholar
• Goh, F. G., Ng, P. Y., Nilsson, M., Kanke, T. & Plevin, R. Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling. Br. J. Pharmacol. 158, 1695–1704 (2009).
  CAS PubMed PubMed Central Google Scholar
• Lohman, R. J. et al. Antagonism of protease activated receptor 2 protects against experimental colitis. J. Pharmacol. Exp. Ther. 25 Oct 2011 (doi:10.1124/jpet.111.187062). This was one of the first studies to show that in vivo pharmacological targeting of PAR2 with a small-molecule peptidomimetic antagonist attenuates experimental colitis.
  Google Scholar
• Barry, G. D. et al. Novel agonists and antagonists for human protease activated receptor 2. J. Med. Chem. 53, 7428–7440 (2010).
  CAS PubMed Google Scholar
• Suen, J. Y., Gardiner, B., Grimmond, S. & Fairlie, D. P. Profiling gene expression induced by protease-activated receptor 2 (PAR2) activation in human kidney cells. PLoS ONE 5, e13809 (2010).
  PubMed PubMed Central Google Scholar
• Suen, J. Y. Regulating Protease Activated Receptor 2. Thesis, Univ. Queensland, Brisbane, Australia (2009).
  Google Scholar
• Hollenberg, M. D. & Saifeddine, M. Proteinase-activated receptor 4 (PAR4): activation and inhibition of rat platelet aggregation by PAR4-derived peptides. Can. J. Physiol. Pharmacol. 79, 439–442 (2001).
  CAS PubMed Google Scholar
• Wu, C. C. et al. Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3. Thromb. Haemost. 87, 1026–1033 (2002).
  CAS PubMed Google Scholar
• Wu, C. C. et al. The role of PAR4 in thrombin-induced thromboxane production in human platelets. Thromb. Haemost. 90, 299–308 (2003).
  CAS PubMed Google Scholar
• Al-Ani, B. et al. Proteinase-activated receptor 2 (PAR(2)): development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands. J. Pharmacol. Exp. Ther. 290, 753–760 (1999).
  CAS PubMed Google Scholar
• O'Brien, P. J. et al. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J. Biol. Chem. 275, 13502–13509 (2000).
  CAS PubMed Google Scholar
• Tressel, S. L. et al. Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models. Methods Mol. Biol. 683, 259–275 (2010).
  Google Scholar
• Covic, L., Misra, M., Badar, J., Singh, C. & Kuliopulos, A. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation. Nature Med. 8, 1161–1165 (2002). This was one of the first studies to demonstrate the utility of intracellular targeting of PARs as a strategy for modulating signalling and cellular responses through these receptors.
  CAS PubMed Google Scholar
• Covic, L., Gresser, A. L., Talavera, J., Swift, S. & Kuliopulos, A. Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides. Proc. Natl Acad. Sci. USA 99, 643–648 (2002).
  CAS PubMed PubMed Central Google Scholar
• Yang, E. et al. Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis. Cancer Res. 69, 6223–6231 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kenakin, T. P. Cellular assays as portals to seven-transmembrane receptor-based drug discovery. Nature Rev. Drug Discov. 8, 617–626 (2009). This is an excellent review discussing novel screening methods for targeting the functional selectivity of GPCRs in drug discovery.
  CAS Google Scholar
• Hanyaloglu, A. C. & von Zastrow, M. Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu. Rev. Pharmacol. Toxicol. 48, 537–568 (2008).
  CAS PubMed Google Scholar
• Marchese, A., Paing, M. M., Temple, B. R. & Trejo, J. G protein-coupled receptor sorting to endosomes and lysosomes. Annu. Rev. Pharmacol. Toxicol. 48, 601–629 (2008).
  CAS PubMed PubMed Central Google Scholar
• Chen, C. H., Paing, M. M. & Trejo, J. Termination of protease-activated receptor-1 signaling by β-arrestins is independent of receptor phosphorylation. J. Biol. Chem. 279, 10020–10031 (2004).
  CAS PubMed Google Scholar
• Paing, M. M., Temple, B. R. & Trejo, J. A tyrosine-based sorting signal regulates intracellular trafficking of protease-activated receptor-1: multiple regulatory mechanisms for agonist-induced G protein-coupled receptor internalization. J. Biol. Chem. 279, 21938–21947 (2004).
  CAS PubMed Google Scholar
• Wang, Y., Zhou, Y., Szabo, K., Haft, C. R. & Trejo, J. Down-regulation of protease-activated receptor-1 is regulated by sorting nexin 1. Mol. Biol. Cell 13, 1965–1976 (2002).
  CAS PubMed PubMed Central Google Scholar
• Swift, S. et al. A novel protease-activated receptor-1 interactor, bicaudal D1, regulates G protein signaling and internalization. J. Biol. Chem. 285, 11402–11410 (2010).
  CAS PubMed PubMed Central Google Scholar
• Defea, K., Schmidlin, F., Dery, O., Grady, E. F. & Bunnett, N. W. Mechanisms of initiation and termination of signalling by neuropeptide receptors: a comparison with the proteinase-activated receptors. Biochem. Soc. Trans. 28, 419–426 (2000).
  CAS PubMed Google Scholar
• Roosterman, D., Schmidlin, F. & Bunnett, N. W. Rab5a and rab11a mediate agonist-induced trafficking of protease-activated receptor 2. Am. J. Physiol. Cell Physiol. 284, C1319–C1329 (2003).
  CAS PubMed Google Scholar
• Bernatowicz, M. S. et al. Development of potent thrombin receptor antagonist peptides. J. Med. Chem. 39, 4879–4887 (1996).
  CAS PubMed Google Scholar
• Damiano, B. P., Derian, C. K., Maryanoff, B. E., Zhang, H. C. & Gordon, P. A. RWJ-58259: a selective antagonist of protease activated receptor-1. Cardiovasc. Drug Rev. 21, 313–326 (2003).
  CAS PubMed Google Scholar
• Kato, Y. et al. Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig. Eur. J. Pharmacol. 473, 163–169 (2003).
  CAS PubMed Google Scholar
• Suen, J. Y. et al. Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110). Br. J. Pharmacol. 1 Aug 2011 (doi:10.1111/j.1476-5381.2011.01610.x).
  CAS PubMed PubMed Central Google Scholar
• Gardell, L. R. et al. Identification and characterization of novel small-molecule protease-activated receptor 2 agonists. J. Pharmacol. Exp. Ther. 327, 799–808 (2008).
  CAS PubMed Google Scholar
• Kanke, T. et al. Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo. Br. J. Pharmacol. 158, 361–371 (2009).
  CAS PubMed PubMed Central Google Scholar
• Chen, H. S. et al. Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1_H_-indazol-3-yl)benzoate (YD-3) derivatives. Bioorg. Med. Chem. 16, 1262–1278 (2008).
  CAS PubMed Google Scholar
• Wu, C. C. et al. YD-3, a novel inhibitor of protease-induced platelet activation. Br. J. Pharmacol. 130, 1289–1296 (2000).
  CAS PubMed PubMed Central Google Scholar